Upload
Featured Recent Articles Topics Login Upload

Search Results for 'stroke warfarin'

stroke warfarin published presentations and documents on DocSlides.

The Canadian Journal of CME June 2003
The Canadian Journal of CME June 2003
by evans
atrophiclichen sclerosusWhat is the difference bet...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Journal Club Jim Hoehns,
Journal Club Jim Hoehns,
by cheryl-pisano
Pharm.D. .. Edoxaban. Oral factor . Xa. inhibito...
Watchman II: PROTECT AF/PREVAIL
Watchman II: PROTECT AF/PREVAIL
by sherrill-nordquist
Meta-Analysis and Implications . David R. Holmes,...
Watchman II: PROTECT AF/PREVAIL
Watchman II: PROTECT AF/PREVAIL
by debby-jeon
Meta-Analysis and Implications . David R. Holmes,...
WATCHMAN™ Left Atrial Appendage Closure Device
WATCHMAN™ Left Atrial Appendage Closure Device
by alexa-scheidler
www.watchmandevice.com. AF is a Growing Problem A...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia
Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia
by adah
NOAC vs Warfarin Atrial Fibrillation Studies – A...
LAA Closure Devices: Protecting Against Stroke
LAA Closure Devices: Protecting Against Stroke
by debby-jeon
Moderator. Ted E. Feldman, MD. Director. Cardiac ...
A Cost Analysis of Bleed Complications from Two Stroke Prev
A Cost Analysis of Bleed Complications from Two Stroke Prev
by giovanna-bartolotta
valvular. Atrial Fibrillation. :. Left Atrial Ap...
Management of atrial fibrillation
Management of atrial fibrillation
by pamella-moone
Mary N. Healy, MS, ARNP-BC. Heart & Vascular ...
Percutaneous Closure of the Left Atrial Appendage
Percutaneous Closure of the Left Atrial Appendage
by cheryl-pisano
versus Warfarin Therapy for Prevention of Stroke ...
Management of
Management of
by marina-yarberry
Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...
Oral anticoagulants in the 21
Oral anticoagulants in the 21
by natalia-silvester
st. century: A practical guide to using newer A...
Dodson Thompson, DO
Dodson Thompson, DO
by lois-ondreau
Northlakes. Community Clinic. Minong, WI. Novel ...
ANTICOAGULATION Blake Wachter
ANTICOAGULATION Blake Wachter
by olivia-moreira
, MD, PhD . Monday Morning Conference. Oct 4, 201...
Pharmacologic and Nonpharmacologic Treatments of Atrial Fibrillation
Pharmacologic and Nonpharmacologic Treatments of Atrial Fibrillation
by kittie-lecroy
Martha Drake MS, FNP-BC. Chicago Heart and Vascul...
Management of atrial fibrillation
Management of atrial fibrillation
by myesha-ticknor
Mary N. Healy, MS, ARNP-BC. Heart & Vascular ...
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
by tatiana-dople
www.onlinecjc.com. ). .  . If your reuse request...
Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know
Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know
by dsuser1
Christopher Granger, . MD. Sean Pokorney, MD. . D...
R eal-world
R eal-world
by liane-varnes
EVI. dence. on . S. troke prevention . I. n pati...
Cost effectiveness of AF monitoring strategies in a
Cost effectiveness of AF monitoring strategies in a
by wang
post-stroke population. Lauren E. . Cipriano. Jeff...
Watchman I: First Report of the 5-Year PROTECT-AF and Exten
Watchman I: First Report of the 5-Year PROTECT-AF and Exten
by debby-jeon
Vivek Y. Reddy, MD. Helmsley Trust Professor of M...
Treatment Options for Stroke Prevention in Nonvalvular Atri
Treatment Options for Stroke Prevention in Nonvalvular Atri
by min-jolicoeur
Percutaneous. Left Atrial Appendage (LAA) Exclus...
Three Cases Vanja Douglas, MD
Three Cases Vanja Douglas, MD
by eliza
Sara & Evan Williams Foundation Endowed . Neur...
UPDATEDPRACTICE
UPDATEDPRACTICE
by singh
Pharmacologic Management of Newly Detected Atria...
Outcomes Associated With
Outcomes Associated With
by daisy
Resuming Warfarin Treatment After . Hemorrhagic St...
IntheClinic
IntheClinic
by unita
page ITC6-2 Treatmentpage ITC6-6 Practice Improvem...
What are the advantages to taking a DOAC Traditional anticoagulants su
What are the advantages to taking a DOAC Traditional anticoagulants su
by carla
What are Direct-Acting Oral Anticoagulants DOACsAN...
Management of Atrial Fibrillation, Stroke, and Bleeding
Management of Atrial Fibrillation, Stroke, and Bleeding
by natalia-silvester
Meta-Analysis of NOACs vs Warfarin. RCT vs Real-W...
Stroke or systemic embolic events in large NOAC trials, vs
Stroke or systemic embolic events in large NOAC trials, vs
by faustina-dinatale
Ruff . et al. ., The Lancet, 2013. Ruff . et al. ...
Digoxin And Mortality in Patients With Atrial Fibrillation
Digoxin And Mortality in Patients With Atrial Fibrillation
by ellena-manuel
Renato D. Lopes, MD, . PhD, FACC. on behalf of th...